EDAP TMS S.A. - ADR Peer Comparison

$5.44

$-0.01 (-0.18%)

As on 17-Jul-2026 09:30EDT

Market cap

$162 Mln

Revenue (TTM)

$63 Mln

P/E Ratio

--

P/B Ratio

23.1

Div. Yield

0 %

Edit

	EDAP TMS S.A. - ADR	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Market cap ($ Mln)	162	12,753	10,906	9,948	9,762
Revenue ($ Mln)	63	1,505	613	785	2,589
Net Profit ($ Mln)	-38.88	160.59	-188.05	41.54	222.40
Net Margin (%)	-61.83	10.67	-30.68	5.29	8.59
RoE (%)	-400.54	10.86	-28.10	1.97	3.04
Price to Earnings	--	79.35	--	251.81	44.47
Price-To-Book	23.08	8.41	16.38	4.86	1.26

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	EDAP TMS S.A. - ADR	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Operating Revenue	62.88	1,504.87	612.84	785.10	2,589.30
Cost of Revenue	33.29	483.98	127.96	384.30	1,245.50
Gross Profit	30.09	942.44	393.22	347.62	1,343.60
Operating Expenses	71.71	833.56	565.37	335.50	1,108.90
Operating Profit (EBIT)	-27.83	187.34	-80.49	65.30	235.00
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-38.72	203.83	-192.83	52.15	350.40
Provision for Tax	0.16	43.24	-4.79	10.61	128.00
Profit after Tax (Net Income)	-38.88	160.59	-188.05	41.54	222.40
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	93.19	0.00	0.00	0.00

Liabilities ($ Mln)

	EDAP TMS S.A. - ADR	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Shareholder's Funds	0.00	1,530.77	682.49	2,112.03	7,173.90
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	0.00	210.18	135.71	705.49	2,116.80
Current Liabilities	0.00	233.78	102.33	132.66	961.30
Total Liabilities	79.00	1,826.52	893.49	2,949.70	10,576.50

Assets ($ Mln)

	EDAP TMS S.A. - ADR	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Non-Current Assets	0.00	630.60	404.74	1,749.63	7,231.50
Current Assets	11.75	1,344.12	515.78	1,200.55	3,020.50
Total Assets	79.00	1,826.52	893.49	2,949.70	10,576.50
Total Debt*	0.00	212.71	102.84	690.94	1,203.70
Net Current Assets	0.00	1,110.35	413.45	1,067.90	2,059.20

Cashflow ($ Mln)

	EDAP TMS S.A. - ADR	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Cash From Operating Activities	-16.41	238.66	-46.34	117.42	532.20
Cash Flow from Investing Activities	-5.72	-404.59	-77.61	-298.47	-189.70
Cash from Financing Activities	8.61	26.53	11.89	-15.21	-283.20
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	EDAP TMS S.A. - ADR	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
ROCE (%)	-57.57	11.76	-22.53	1.79	8.98
ROE (%)	-400.54	10.86	-28.10	1.97	3.04
ROA (%)	-61.73	7.95	-18.00	1.36	2.02
EBIT Margin (%)	-60.74	13.63	-30.58	9.87	-5.99
Net Margin (%)	-61.83	10.67	-30.68	5.29	8.59
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	EDAP TMS S.A. - ADR	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Revenue Growth (%)	-0.22	17.55	41.55	16.49	1.37
EBIT Growth (%)	-86.40	17.49	-116.42	920.91	-131.06
Net Profit Growth (%)	-85.01	8.72	-102.66	400.42	-30.32
EPS Growth (%)	-84.33	8.12	-96.88	394.30	-29.66
Book Value Growth (%)	--	17.33	-12.65	2.16	2.19

Valuation Ratios

	EDAP TMS S.A. - ADR	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Price / Earnings	-4.20	68.93	-34.59	189.42	--
Price / Book Value	6.35	8.58	9.90	4.86	--
Dividend Yield (%)	--	--	--	0.00	--
EV/EBITDA	-5.33	53.25	-43.50	81.02	--
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	EDAP TMS S.A. - ADR	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Debt to Equity	1.43	0.00	0.00	0.26	0.11
Short term debt to equity ratio	0.48	0.01	0.00	0.01	0.06
Current Ratio	1.54	5.75	5.04	9.05	3.14
Quick Ratio	1.25	3.86	4.46	7.64	2.33
Interest Coverage	-4.06	157.91	-38.31	3.36	8.18

Operating Efficiency Ratios

	EDAP TMS S.A. - ADR	Penumbra (PEN)	Glaukos Corp (GKOS)	Repligen (RGEN)	Bio-Rad Laboratories
Debtors to sales (%)	0.00	12.65	22.67	20.09	17.06
Asset Turnover	1.00	0.74	0.59	0.26	0.24
Receivable days	110.68	46.54	60.95	72.41	65.39
Inventory Days	132.14	331.92	193.84	146.53	221.09
Payable days	135.50	26.16	60.19	29.05	37.02
Cash Conversion Cycle	107.32	352.30	194.60	189.88	249.46

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly